generics

Gottlieb lays out FDA plans to speed generic reviews, spur label updates
Gottlieb lays out FDA plans to speed generic reviews, spur label updates
Biopharma Dive
FDA
Scott Gottlieb
generics
Flag link:
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Reuters
Indivior
FDA
generics
Suboxone Film
opioids
opioid addiction
Flag link:
Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions
Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions
NY Shock Exchange
Allergan
Restasis
Kroger
Walgreens
generics
Flag link:
A Look at FDA's FY2018 Generic Drug Performance
A Look at FDA's FY2018 Generic Drug Performance
RAPS.org
generics
Flag link:
Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024
Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024
Center for Biosimilars
biosimilars
patent cliff
generics
Flag link:
What to Expect for AstraZeneca in Fiscal 2018
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
AstraZeneca
guidance
generics
Crestor
Japan
Europe
Flag link:
CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect
CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect
Fierce Pharma
drug reps
layoffs
Acorda Therapeutics
AMPYRA
generics
Flag link:
FDA: Generics Approved in 2017 Led to $8.8B in Savings
FDA: Generics Approved in 2017 Led to $8.8B in Savings
RAPS.org
FDA
generics
drug pricing
drug approvals
Flag link:
EU makes it easier for companies to produce generic medicines for export
EU makes it easier for companies to produce generic medicines for export
Reuters
Europe
European Commission
generics
exporting
Flag link:
FDA demonizes pharma over generics, but most company reputations can take the blow
FDA demonizes pharma over generics, but most company reputations can take the blow
Fierce Pharma
generics
pharma industry
FDA
reputation
Flag link:
Tribe taking steps to ‘ramp up’ drug patent business
Tribe taking steps to ‘ramp up’ drug patent business
Drug Delivery Business News
Native Americans
Allergan
generics
patents
Flag link:
FDA calls out 39 drug companies for allegedly blocking access to generics
FDA calls out 39 drug companies for allegedly blocking access to generics
Stat
JNJ
Actelion
Celgene
Gilead
Novartis
Pfizer
Valeant Pharmaceuticals
generics
FDA
Flag link:
FDA website to call out branded drugmakers for blocking generics
FDA website to call out branded drugmakers for blocking generics
Biopharma Dive
FDA
generics
drug pricing
Flag link:
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
GoinPharma
Novartis
dermatology
generics
M&A
Aurobindo
Shanghai Fosun Pharmaceutical
Apollo Global Management
Flag link:
Perrigo postpones launch of generic to Teva’s ProAir
Perrigo postpones launch of generic to Teva’s ProAir
GoinPharma
Perrigo
Teva Pharmaceutical
ProAir
generics
Flag link:
FDA Denies Mylan Petition on Advair Generics
FDA Denies Mylan Petition on Advair Generics
RAPS.org
FDA
Mylan Labs
generics
Advair
Flag link:
Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die
Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die
Yahoo/Bloomberg
GSK
Advair
asthma
generics
Flag link:
Appeals Court Struck Down a Price Gouging Law – What About Other Approaches
Appeals Court Struck Down a Price Gouging Law – What About Other Approaches
CP Wire
state legislation
legislation
generics
Flag link:
Healthcare on the Hill - A Look at the Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (S.974)
Healthcare on the Hill - A Look at the Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (S.974)
CP WIre
Healthcare on the Hill
Senate
CREATES Act of 2017
generics
Flag link:
U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
Reuters
FTV
Impax Laboratories
Amneal
generics
M&A
Flag link:

Pages